Liht Cannabis Corp. (C:LIHT*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 102-1561 Sutherland Ave
Tel: N/A
IR: See website
Key People
Linda Sampson
President, Chief Operating Officer, Director
Rahim Mohamed
Chief Executive Officer, Director
Hanspaul Pannu
Chief Financial Officer
Corey Klassen
Vice President of Corporate Development, Director
Business Overview
Liht Cannabis Corp, formerly Marapharm Ventures Inc is a Canada-based company, which focuses on the health industry, including medical and recreational cannabis products. It engages in the field of maximizing the purity and yield of cannabis, as well as in the development of a prescribed dosage formula for medical patients. The Company has the following projects, which are operated under the Company and its subsidiaries: California includes two industrial properties in Desert Hot Springs; Canada project owns parcel of land in Kelown; Las Vegas is constructing Cannabis cultivation facility in the Apex business park, situated within the city of North Las Vegas, Nevada; Marapharm.TV is a broadcasting channel with programs on the cannabis industry and providing weekly market reports of the Company's stock activity and updates on its operations; Washington State owns approximately 13.6 acres of industrial land and buildings.
Financial Overview
For the six months ended 30 September 2018, Liht Cannabis Corp revenues increased from C$230K to C$716K. Net income totaled C$2.2M vs. loss of C$4.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Share ofGain in Equity Investment increase from C$347K (expense) to C$1.4M (income), Commissions decrease of 99% to C$5K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $72.85M as of Sep 30, 2018
Annual revenue (TTM): $0.64M as of Sep 30, 2018
EBITDA (TTM): -$8.45M as of Sep 30, 2018
Net annual income (TTM): -$13.86M as of Sep 30, 2018
Free cash flow (TTM): -$23.18M as of Sep 30, 2018
Net Debt Last Fiscal Year: $0.49M as of Sep 30, 2018
Shares outstanding: 233,327,532 as of Jan 8, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization